Health

Mixed Response to FDA’s Planned Makeover of Nutrition Labels

Mixed Response to FDA’s Planned Makeover of Nutrition Labels

Proposed updates to label draw praise from public health groups, concern from food industry.

Alcohol Bureau Will Not Revise Labeling Rules

Alcohol Bureau Will Not Revise Labeling Rules

TTB withholds “gluten-free” label for specially processed beers.

The Promise and Perils of Gluten-Free Labels

The Promise and Perils of Gluten-Free Labels

The FDA’s gluten-free labeling rule may lead manufacturers to inform some consumers while misleading others.

New Surgeon General Report Examines Smoking Fifty Years After Initial Report

New Surgeon General Report Examines Smoking Fifty Years After Initial Report

New report examines progress in reducing smoking and makes the case for continued policy efforts.

How Well is Obamacare Working?

How Well is Obamacare Working?

Panel of Penn experts share latest research on the Affordable Care Act’s implementation.

Inflating Civil Penalties

Inflating Civil Penalties

FDA adjusts maximum civil money penalties to account for inflation.

The Case for Performance-Based Regulation of Food and Beverage Retailers

The Case for Performance-Based Regulation of Food and Beverage Retailers

An alternative regulatory approach could entice business to create a healthier American diet.

What is the Future for Genetic Testing and Personalized Medicine?

What is the Future for Genetic Testing and Personalized Medicine?

FDA declares personalized medicine “has clearly arrived.”

Workplace Injury Reports to Go Online

Workplace Injury Reports to Go Online

OSHA proposes requirement for employers to submit injury and illness reports electronically.

A New Tax-and-Spend Strategy to Fight Obesity

A New Tax-and-Spend Strategy to Fight Obesity

Scholar proposes a manufacturers’ excise tax to fund obesity-prevention efforts.

FDA to Require Medical Device ID Numbers

FDA to Require Medical Device ID Numbers

New agency rule designed to help identify faulty medical devices.

Learning from the FDA’s Plan B Fiasco

Learning from the FDA’s Plan B Fiasco

Plan B episode calls for reconsidering the scope of judicial review and the role of politics in rulemaking.